MAPS Act aims to enhance federal coordination in identifying and mitigating health and national security risks through essential medicines list.
The Mapping America's Pharmaceutical Supply Act (MAPS Act) seeks to improve federal coordination in identifying and mitigating health and national security risks. It mandates the maintenance of an Essential Medicines List, which includes active pharmaceutical ingredients and drugs critical for health care and national defense. The Act requires a comprehensive risk assessment of the supply chains for these essential medicines, focusing on vulnerabilities and cybersecurity threats. Additionally, it establishes a monitoring system to map pharmaceutical supply chains using data analytics.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.